文献速递贫血与红细胞疾病MDS 与骨髓增殖性肿瘤

体细胞HLA突变揭示I类介导的自身免疫在再生障碍性贫血及其克隆并发症中的作用

Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications.
PubMed 文献 · Blood Adv · 2017-01-01

该研究通过靶向深度测序HLA I类基因和SNP-A基因分型,在66例获得性再生障碍性贫血(aAA)患者中筛查体细胞HLA I类缺失,发现11例(17%)存在体细胞HLA丢失,涉及HLA-A*33:03、HLA-A*68:01、HLA-B*14:02和HLA-B*40:02等位基因的13个功能丧失突变。携带靶向HLA等位基因的患者疾病病程更严重、克隆并发症更频繁。

要点

  • 66例aAA患者中11例(17%)检出体细胞HLA I类功能丧失突变。
  • HLA-B*14:02和HLA-B*40:02在aAA患者中显著多于种族匹配对照。
  • 继承靶向HLA等位基因者疾病更重、克隆并发症及继发MDS更频繁。

核心结论

  • 复发性HLA I类突变提供了aAA中HLA I类驱动自身免疫占主导的有力证据,并建立了aAA患者免疫遗传学与克隆演化之间的新联系。

研究设计与样本

  • 研究采用HLA I类基因靶向深度测序联合单核苷酸多态性阵列(SNP-A)基因分型,筛查66例获得性再生障碍性贫血(aAA)患者的体细胞HLA I类丢失。

主要发现

  • 66例aAA患者中11例(17%)检出体细胞HLA丢失,共13个功能丧失突变,涉及HLA-A*33:03、HLA-A*68:01、HLA-B*14:02和HLA-B*40:02等位基因。
  • 3例患者存在一个以上靶向同一HLA等位基因的突变。
  • HLA-B*14:02和HLA-B*40:02在aAA患者中显著多于种族匹配对照。
  • 继承靶向HLA等位基因的患者无论HLA突变状态如何,经WES、SNP-A和中期细胞遗传学评估,疾病病程更严重、克隆并发症更频繁,继发性MDS也更频繁。

关键数值与推荐

  • 体细胞HLA I类丢失见于11/66例aAA患者(17%)。
  • 检出13个功能丧失突变,分布于HLA-A*33:03、HLA-A*68:01、HLA-B*14:02和HLA-B*40:02等位基因。
  • 3例患者有超过一个突变靶向同一HLA等位基因。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Acquired aplastic anemia (aAA) is an acquired deficiency of early hematopoietic cells, characterized by inadequate blood production, and a predisposition to myelodysplastic syndrome (MDS) and leukemia. Although its exact pathogenesis is unknown, aAA is thought to be driven by Human Leukocyte Antigen (HLA)-restricted T cell immunity, with earlier studies favoring HLA class II-mediated pathways. Using whole exome sequencing (WES), we recently identified two aAA patients with somatic mutations in HLA class I genes. We hypothesized that HLA class I mutations are pathognomonic for autoimmunity in aAA, but were previously underappreciated because the Major Histocompatibility Complex (MHC) region is notoriously difficult to analyze by WES. Using a combination of targeted deep sequencing of HLA class I genes and single nucleotide polymorphism array (SNP-A) genotyping we screened 66 aAA patients for somatic HLA class I loss. We found somatic HLA loss in eleven patients (17%), with thirteen loss-of-function mutations in HLA-A*33:03, HLA-A*68:01, HLA-B*14:02 and HLA-B*40:02 alleles. Three patients had more than one mutation targeting the same HLA allele. Interestingly, HLA-B*14:02 and HLA-B*40:02 were significantly overrepresented in aAA patients, compared to ethnicity-matched controls. Patients who inherited the targeted HLA alleles, regardless of HLA mutation status, had a more severe disease course with more frequent clonal complications as assessed by WES, SNP-A, and metaphase cytogenetics, and more frequent secondary MDS. The finding of recurrent HLA class I mutations provides compelling evidence for a predominant HLA class I-driven autoimmunity in aAA, and establishes a novel link between aAA patients' immunogenetics and clonal evolution.

来源:Blood Adv,查看原文。版权归原作者所有。

引用

  1. Babushok DV, Duke JL, Xie HM, et al. Somatic HLA Mutations Expose the Role of Class I-Mediated Autoimmunity in Aplastic Anemia and its Clonal Complications. Blood Adv. 2017. PMID: 28971166

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。